SHISEIDO WASO KOSHIRICE ACNE CALMING TREATMENT- salicylic acid gel 
SHISEIDO AMERICAS CORPORATION

----------

SHISEIDO WASO KOSHIRICE ACNE CALMING TREATMENT

Drug Facts

Active ingredients

SALICYLIC ACID 0.5%

Purpose

Acne medication

Uses

Warnings

For external use only

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

  • If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive Ingredients

WATER▪BUTYLENE GLYCOL▪DIPROPYLENE GLYCOL▪DIMETHICONE▪PEG-6▪PEG-32▪PEG-240/HDI COPOLYMER BIS-DECYLTETRADECETH-20 ETHER▪ERYTHRITOL▪GLYCERIN▪PEG/PPG-14/7 DIMETHYL ETHER▪DIPOTASSIUM GLYCYRRHIZATE▪PAEONIA ALBIFLORA ROOT EXTRACT▪HYDROLYZED RICE EXTRACT▪CITRUS DEPRESSA PEEL EXTRACT▪ISOSTEARYL ALCOHOL▪CARBOMER▪POTASSIUM HYDROXIDE▪SODIUM METAPHOSPHATE▪ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER▪BHT▪PHENOXYETHANOL▪BENZOIC ACID▪ <M095042-811>

Other information

cap contains natural materials that may change color/texture over time. This doesn't affect product quality. Wipe any liquid or dirt off the cap and store in a dry area.

Questions or comments?

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 20 mL Tube Carton

WASO
SHISEIDO
GINZA TOKYO

KOSHIRICE

ACNE CALMING
TREATMENT

+ SALICYLIC ACID

SPOT CLEAR

RICE
HYOGO

20mL NET WT. .7 OZ.

PRINCIPAL DISPLAY PANEL - 20 mL Tube Carton
SHISEIDO WASO KOSHIRICE ACNE CALMING TREATMENT 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-615
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.1 g  in 20 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ)  
POLYETHYLENE GLYCOL 1600 (UNII: 1212Z7S33A)  
GLYCERIN (UNII: PDC6A3C0OX)  
ERYTHRITOL (UNII: RA96B954X6)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
ISOSTEARYL ALCOHOL (UNII: Q613OCQ44Y)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
PEG/PPG-14/7 DIMETHYL ETHER (UNII: 6DNW9T7YT2)  
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)  
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
SODIUM POLYMETAPHOSPHATE (UNII: P1BM4ZH95L)  
PAEONIA LACTIFLORA ROOT (UNII: 3Z3866YW6P)  
TANGERINE PEEL (UNII: JU3D414057)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-615-601 in 1 CARTON01/01/2021
120 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH DRUGM00601/01/2021
Labeler - SHISEIDO AMERICAS CORPORATION (193691821)
Establishment
NameAddressID/FEIBusiness Operations
Shiseido America Inc.782677132ANALYSIS(58411-615) , MANUFACTURE(58411-615)

Revised: 11/2020
Document Id: 88ad3d28-7f9f-4ae0-bfb8-551885d71cad
Set id: 3b584705-21a8-4e37-96cc-f9c8058db5c4
Version: 2
Effective Time: 20201118
 
SHISEIDO AMERICAS CORPORATION